Quantitation of efletirizine in human plasma and urine using automated solid-phase extraction and column-switching high-performance liquid chromatography

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 730, Issue 2, 1999, Pages 239-247

  Coe, R A ^a   DeCesare, L S ^b   Lee, J W ^a  

^a MDS Inc   (Canada)

^b UCB PHARMA   (Belgium)

Author keywords

Efletirizine

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; EFLETIRIZINE; HYDROXYZINE; NORASTEMIZOLE; PSEUDOEPHEDRINE; TERFENADINE;

ANALYTIC METHOD; ARTICLE; AUTOANALYSIS; AUTOMATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG URINE LEVEL; HUMAN; ION PAIR CHROMATOGRAPHY; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL NOISE RATIO; SOLID PHASE EXTRACTION;

ACETATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HISTAMINE H1 ANTAGONISTS; HUMANS; PIPERAZINES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0033021751     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(99)00223-6     Document Type: Article

References (10)

1. Graul A., Leeson P., Castaner R. Drugs Future. 22:1997;626-628.
2. UCB Pharma, Inc., Smyrna, GA, personal communication.
3. Moncrieff J. J. Chromatogr. 121:1992;128-130.
4. Rosseel M.T., Lefebvre R.A. J. Chromatogr. 103:1991;504-510.
5. Lefebvre R.A., Rosseel M.T., Bernheim J. Int. J. Clin. Pharm. Res. VIII:1988;463-470.
6. Tracqui A., Kintz P., Mangin P. J. Forensic Sci. 40:1995;254-262.
7. Baltes E., Coupez R., Brouwers L., Gobert J. J. Chromatogr. 74:1988;149-155.
8. Pandya K.K., Bangaru R.A., Gandhi T.P., Modi I.A., Modi R.I., Chakravarthy B.K. J. Pharm. Pharmacol. 48:1996;510-513.
9. Chen X.A., Franke J.P., Ensing D., Wijsbeek J., deZeeuw R.A. J. Anal. Toxicol. 17:1993;421-426.
10. Shah V.P., Midah K.K., Digne S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309.